C. DIFF QUIK CHEK COMPLETE^®

C.DIFF QUIK CHEK COMPLETE^® 检测提供不同于其他任何独立检测的完整诊断信息。根据最新的 IDSA/SHEA¹ 和 ESCMID² 指南建议对进入样本同时进行 GDH 和毒素 A & B 检测，在 30 分钟内提供有效的艰难梭菌结果。

优势

C.DIFF QUIK CHEK COMPLETE^® 对多达 90% 的样品只需一次检测即可获得最终结果

30 分钟内即可获得结果

可以进行样品批量检测或按需进行个别检测

该检测适用于任意稠度的样本检测，并可用于采用 Cary-Blair 氏、C&S 等运送培养基储存的样本

详细信息

C. DIFF QUIK CHEK COMPLETE ^®由 TECHLAB Inc. 按照许可进行开发和制造。

视频

播放我们的交互式产品演示，了解 C. DIFF QUIK CHEK COMPLETE^® 检测的工作方式。

查看 QUIK CHEK™ 相对于侧向流技术的优势。

Updated IDSA/SHEA guidelines published in 2018 recommend:
- Against the use of NAAT alone when there are no pre-agreed institutional criteria for patient stool submission, due to inadequate positive predictive value.
- Use of a stool toxin test as part of a multi-step algorithm (ie, glutamate dehydrogenase [GDH] plus toxin; GDH plus toxin, arbitrated by nucleic acid amplification test [NAAT]; or NAAT plus toxin) for all specimens received in the clinical laboratory whether there are or are no pre-agreed institutional criteria for patient stool submission.
- Or screening samples simultaneously with both a GDH and toxin A/B EIA with an assay that includes both these targets in one system (C. DIFF QUIK CHEK COMPLETE^®).
Updated ESCMID guidelines published in 2016 recommend:
- Against the use of a single rapid test as a standalone test, due to inadequate positive predictive value.
- The use of a 2-step algorithm starting with either GDH EIA or NAAT. Samples with a negative first test
  result can be reported as negative. Samples with a positive first test result should be tested further with a Toxin A & B EIA.
- Or screen samples simultaneously with both a GDH and toxin A/B EIA with an assay that includes both these targets in one system (C. DIFF QUIK CHEK COMPLETE^®).
C. DIFF QUIK CHEK COMPLETE^® Package Insert

C. DIFF QUIK CHEK COMPLETE®